Columbia University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1754-01-01

Employees: 20.8K

Market Cap: -

Website: https://www.arch.columbia.edu

Clinical Trials

TREAT to Improve Cardiometabolic Health

Not Applicable

Active, not recruiting

Conditions: Prediabetes
Overweight and Obesity

Interventions: Behavioral: HABIT
Behavioral: TRE

First Posted Date: 2020-07-10

Last Posted Date: 2025-05-18

Lead Sponsor: Columbia University

Target Recruit Count: 57

Registration Number: NCT04465721

Locations: 🇺🇸
Columbia University, New york, New York, United States

Understanding Adoption for Clean Cookstoves: A Demand Study

Not Applicable

Completed

Conditions: Consumer Behavior

Interventions: Behavioral: Distance allocation
Behavioral: LPG subsidy

First Posted Date: 2020-07-02

Last Posted Date: 2024-02-28

Lead Sponsor: Columbia University

Target Recruit Count: 890

Registration Number: NCT04454944

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States
🇬🇭
Kintampo Medical Research Center, Kintampo, Ghana

Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence

Recruiting

Conditions: SARS-CoV 2
COVID-19
Corona Virus Infection

First Posted Date: 2020-06-25

Last Posted Date: 2025-01-06

Lead Sponsor: Columbia University

Target Recruit Count: 800

Registration Number: NCT04448145

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Pediatrics HOT COVID-19 Database in NY Tristate

Completed

Conditions: COVID-19
Pediatric Cancer
Immune System Disorder
Hemoglobinopathies

First Posted Date: 2020-06-24

Last Posted Date: 2023-05-03

Lead Sponsor: Columbia University

Target Recruit Count: 77

Registration Number: NCT04445402

Locations: 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

Modulation Of Frontal EEG Alpha Oscillations During Maintenance and Emergence Phases of General Anesthesia

Not Applicable

Withdrawn

Conditions: Postoperative Delirium

Interventions: Procedure: Alpha Optimization
Behavioral: Emergence from anesthesia with propofol

First Posted Date: 2020-06-23

Last Posted Date: 2025-02-17

Lead Sponsor: Columbia University

Target Recruit Count: 600

Registration Number: NCT04443517

Locations: 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

MyHand 2: An Active Hand Orthosis for Stroke Patients

Not Applicable

Recruiting

Conditions: Stroke
Hemiparesis

Interventions: Device: MyHand Device

First Posted Date: 2020-06-17

Last Posted Date: 2025-04-03

Lead Sponsor: Columbia University

Target Recruit Count: 25

Registration Number: NCT04436042

Locations: 🇺🇸
Columbia University Irving Medical Center, New York City, New York, United States

Awake Proning in COVID-19 Patients With Hypoxemic Respiratory Failure

Completed

Conditions: Coronavirus Infection
Oxygen Deficiency

Interventions: Other: Awake proning

First Posted Date: 2020-05-29

Last Posted Date: 2022-03-09

Lead Sponsor: Columbia University

Target Recruit Count: 29

Registration Number: NCT04408222

Locations: 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

TXA127 for the Treatment of Severe COVID-19

Phase 2

Completed

Conditions: COVID-19

Interventions: Drug: TXA127
Drug: Placebo

First Posted Date: 2020-05-26

Last Posted Date: 2022-07-27

Lead Sponsor: Columbia University

Target Recruit Count: 22

Registration Number: NCT04401423

Locations: 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

Effects of ACC Inhibitor on Lipid and Lipoprotein Metabolism

Phase 1

Withdrawn

Conditions: NAFLD (Nonalcoholic Fatty Liver Disease)
NASH (Nonalcoholic Steatohepatitis)

Interventions: Drug: Placebo
Drug: PF-05221304

First Posted Date: 2020-05-20

Last Posted Date: 2021-08-25

Lead Sponsor: Columbia University

Registration Number: NCT04395950

Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection

Phase 2

Terminated

Conditions: COVID-19

Interventions: Other: Placebo
Drug: Clazakizumab

First Posted Date: 2020-05-08

Last Posted Date: 2022-04-08

Lead Sponsor: Columbia University

Target Recruit Count: 1

Registration Number: NCT04381052

Locations: 🇺🇸
Columbia University Medical Center / New York Presbyerian Hospital, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy